Published in Am J Perinatol on December 05, 2011
Connecting teratogen-induced congenital heart defects to neural crest cells and their effect on cardiac function. Birth Defects Res C Embryo Today (2014) 0.76
The incidence of congenital heart disease. J Am Coll Cardiol (2002) 16.13
Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation (1999) 3.12
First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome. Obstet Gynecol (2005) 2.40
Early diagnosis of fetal congenital heart disease by transvaginal echocardiography. Ultrasound Obstet Gynecol (1993) 1.53
Prenatal detection of congenital heart disease: factors affecting obstetric management and survival. Am J Obstet Gynecol (1988) 1.49
Trends and outcomes after prenatal diagnosis of congenital cardiac malformations by fetal echocardiography in a well defined birth population, Atlanta, Georgia, 1990-1994. J Am Coll Cardiol (1996) 1.49
Nuchal translucency and the risk of congenital heart disease. Obstet Gynecol (2007) 1.46
Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol (2001) 1.33
Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol (2001) 1.28
A systematic review of the accuracy of first-trimester ultrasound examination for detecting major congenital heart disease. Ultrasound Obstet Gynecol (2006) 1.25
Diagnosis, transport, and outcome in fetuses with left ventricular outflow tract obstruction. J Thorac Cardiovasc Surg (1991) 1.24
Outcome of prenatally detected cardiac malformations. Am J Cardiol (1992) 1.12
Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan. Ultrasound Obstet Gynecol (2006) 1.11
Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation. Ultrasound Obstet Gynecol (1996) 1.05
Fetal cardiac abnormalities identified prior to 14 weeks' gestation. Ultrasound Obstet Gynecol (2002) 1.03
Assessment of fetal anatomy at the 11-14-week ultrasound examination. Ultrasound Obstet Gynecol (2004) 1.03
Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects. Ultrasound Obstet Gynecol (1997) 1.01
Screening for congenital heart disease with the four-chamber view of the fetal heart. Am J Obstet Gynecol (1992) 0.94
Clinical impact of first and early second trimester fetal echocardiography on high risk pregnancies. Heart (2004) 0.93
Routine fetal cardiac screening: what are we doing and what should we do? Prenat Diagn (2004) 0.90
Early prenatal diagnosis of major cardiac anomalies in a high-risk population. Prenat Diagn (2002) 0.87
Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency. Br J Obstet Gynaecol (1999) 0.87
Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population. Br J Obstet Gynaecol (1999) 0.87
Fetal echocardiography during routine first-trimester screening: a feasibility study in an unselected population. Prenat Diagn (2006) 0.86
Factors influencing the outcome of congenital heart disease detected prenatally. Arch Dis Child (1991) 0.85
Structural cardiac abnormalities in the fetus: reliability of prenatal diagnosis and outcome. Br J Obstet Gynaecol (1990) 0.85
Prevalence of increased nuchal translucency in fetuses with congenital cardiac disease and a normal karyotype. Cardiol Young (2009) 0.84
Elevated first-trimester nuchal translucency increases the risk of congenital heart defects. Am J Obstet Gynecol (2005) 0.82
Early fetal echocardiography: heart biometry and visualization of cardiac structures between 10 and 15 weeks' gestation. J Ultrasound Med (2006) 0.82
Indications for fetal echocardiography. Pediatr Cardiol (2004) 0.81
How successful is fetal echocardiographic examination in the first trimester of pregnancy? Ultrasound Obstet Gynecol (2002) 0.80
Screening for congenital heart disease: a move toward earlier echocardiography. Am J Perinatol (2007) 0.79
Fetal echocardiography. Clin Obstet Gynecol (1988) 0.78
Detection rate of early fetal echocardiography and in utero development of congenital heart defects. J Ultrasound Med (2006) 0.77
Early fetal echocardiography--a reliable prenatal diagnosis tool. Am J Obstet Gynecol (2005) 0.77
Diagnosis of congenital cardiac defects between 11 and 14 weeks' gestation in high-risk patients. J Ultrasound Med (2002) 0.77
Routine prenatal screening for congenital heart disease: what can be expected? A decision-analytic approach. Am J Public Health (1997) 0.76
Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med (2010) 5.43
De novo mutations in histone-modifying genes in congenital heart disease. Nature (2013) 5.15
Twin-twin transfusion syndrome. Am J Obstet Gynecol (2012) 3.40
A prospective, randomized, multicenter trial of amnioreduction vs selective fetoscopic laser photocoagulation for the treatment of severe twin-twin transfusion syndrome. Am J Obstet Gynecol (2007) 2.73
Predictors of massive blood loss in women with placenta accreta. Am J Obstet Gynecol (2011) 1.86
Early developmental outcome in children with hypoplastic left heart syndrome and related anomalies: the single ventricle reconstruction trial. Circulation (2012) 1.72
Regionalization of care for obstetric hemorrhage and its effect on maternal mortality. Obstet Gynecol (2010) 1.56
Scientific evidence underlying the American College of Obstetricians and Gynecologists' practice bulletins. Obstet Gynecol (2011) 1.55
Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection. Obstet Gynecol (2020) 1.40
The impact of prenatal diagnosis of complex congenital heart disease on neonatal outcomes. Pediatr Cardiol (2010) 1.28
Intermediate-term mortality and cardiac transplantation in infants with single-ventricle lesions: risk factors and their interaction with shunt type. J Thorac Cardiovasc Surg (2012) 1.21
Association of impaired linear growth and worse neurodevelopmental outcome in infants with single ventricle physiology: a report from the pediatric heart network infant single ventricle trial. J Pediatr (2012) 1.17
Maternal sepsis mortality and morbidity during hospitalization for delivery: temporal trends and independent associations for severe sepsis. Anesth Analg (2013) 1.14
Cause, timing, and location of death in the Single Ventricle Reconstruction trial. J Thorac Cardiovasc Surg (2012) 1.14
Neonatal outcomes associated with intestinal abnormalities diagnosed by fetal ultrasound. J Pediatr Surg (2009) 1.04
Prenatal diagnosis and risk factors for preoperative death in neonates with single right ventricle and systemic outflow obstruction: screening data from the Pediatric Heart Network Single Ventricle Reconstruction Trial(∗). J Thorac Cardiovasc Surg (2010) 1.04
Morbidity and mortality of peripartum hysterectomy. Obstet Gynecol (2010) 1.00
Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering. Biol Blood Marrow Transplant (2006) 1.00
Higher rate of stillbirth at the extremes of reproductive age: a large nationwide sample of deliveries in the United States. Am J Obstet Gynecol (2006) 0.99
Prenatal diagnosis of congenital heart disease and birth outcomes. Pediatr Cardiol (2012) 0.95
A predictive model for neurodevelopmental outcome after the Norwood procedure. Pediatr Cardiol (2012) 0.95
Pregnancy-associated death: a qualitative systematic review of homicide and suicide. Obstet Gynecol Surv (2005) 0.92
Antenatal sonographic prediction of twin chorionicity. Am J Obstet Gynecol (2006) 0.87
Twin chorionicity and the risk of stillbirth. Obstet Gynecol (2008) 0.87
Fetal diaphragmatic hernia and upper limb anomalies suggest Brachmann-de Lange syndrome. Prenat Diagn (2002) 0.86
Maternal medical disease and stillbirth. Clin Obstet Gynecol (2010) 0.85
Fetal magnetic resonance imaging: a review. Curr Opin Obstet Gynecol (2007) 0.85
Prenatal lung-head ratio: threshold to predict outcome for congenital diaphragmatic hernia. J Matern Fetal Neonatal Med (2011) 0.85
Founder Fukutin mutation causes Walker-Warburg syndrome in four Ashkenazi Jewish families. Prenat Diagn (2009) 0.85
Increased induction of allogeneic-specific cord blood CD4+CD25+ regulatory T (Treg) cells: a comparative study of naïve and antigenic-specific cord blood Treg cells. Exp Hematol (2005) 0.84
Prenatal sonographic diagnosis of congenital heart disease and intrauterine growth restriction: a case-control study. J Clin Ultrasound (2007) 0.84
Practice variability and outcomes of coil embolization of aortopulmonary collaterals before Fontan completion: a report from the Pediatric Heart Network Fontan Cross-Sectional Study. Am Heart J (2011) 0.83
Immaturity of IL-18 gene expression and protein production in cord blood (CB) versus peripheral blood (PB) mononuclear cells and differential effects in natural killer (NK) cell development and function. Br J Haematol (2005) 0.82
Referral for fetal echocardiography is associated with increased maternal anxiety. J Psychosom Obstet Gynaecol (2010) 0.82
Persistent antegrade pulmonary blood flow post-glenn does not alter early post-Fontan outcomes in single-ventricle patients. Ann Thorac Surg (2007) 0.81
Vaginal birth after cesarean delivery in twin gestations: a large, nationwide sample of deliveries. Am J Obstet Gynecol (2006) 0.80
Maternal physiologic parameters in relationship to systemic inflammatory response syndrome criteria: a systematic review and meta-analysis. Obstet Gynecol (2014) 0.80
Interleukin (IL)-15 in combination with IL-2, fms-like tyrosine kinase-3 ligand and anti-CD3 significantly enhances umbilical cord blood natural killer (NK) cell and NK-cell subset expansion and NK function. Cytotherapy (2011) 0.80
Going out on a limb for a difficult diagnosis: a case report. Clin Imaging (2013) 0.79
Screening for congenital heart disease: a move toward earlier echocardiography. Am J Perinatol (2007) 0.79
The North American Fetal Therapy Network Consensus Statement: prenatal management of uncomplicated monochorionic gestations. Obstet Gynecol (2015) 0.79
Comparison of method of conception in fetuses undergoing echocardiography at a tertiary referral center. Prenat Diagn (2014) 0.78
Gastroschisis: incidence and prediction of growth restriction. J Perinat Med (2015) 0.78
Selective termination procedures in monochorionic pregnancies. Semin Perinatol (2005) 0.78
Maternal Deaths Due to Sepsis in the State of Michigan, 1999-2006. Obstet Gynecol (2015) 0.78
Major fetal structural malformations: the role of new imaging modalities. Am J Med Genet C Semin Med Genet (2007) 0.78
Screening for fetal heart disease with ultrasound. Clin Obstet Gynecol (2003) 0.77
Preterm premature rupture of membranes complicating twin pregnancy: management considerations. Clin Obstet Gynecol (2011) 0.77
Screening for domestic violence. Screening for partner violence makes a difference and saves lives. BMJ (2002) 0.76
Fetal omphalocele ratios predict outcomes in prenatally diagnosed omphalocele. Am J Obstet Gynecol (2011) 0.76
Impact of change in delivery practice on neonatal and maternal outcomes in cases of significant congenital heart disease. Congenit Heart Dis (2014) 0.75
Clinical research careers: reports from a NHLBI pediatric heart network clinical research skills development conference. Am Heart J (2011) 0.75
Advances in ultrasound imaging for congenital malformations during early gestation. Birth Defects Res A Clin Mol Teratol (2015) 0.75
Outcomes of the infant Ross procedure for congenital aortic stenosis followed into adolescence. J Thorac Cardiovasc Surg (2012) 0.75
Maternal congenital cardiac disease: outcomes of pregnancy in a single tertiary care center. Obstet Gynecol (2008) 0.75
Circulating Cell-Free DNA to Determine the Fetal RHD Status in All Three Trimesters of Pregnancy. Obstet Gynecol (2016) 0.75
Practice patterns and knowledge of obstetricians and gynecologists regarding placenta accreta. J Matern Fetal Neonatal Med (2013) 0.75
Previous cesarean delivery: understanding and satisfaction with mode of delivery in a subsequent pregnancy in patients participating in a formal vaginal birth after cesarean counseling program. Am J Perinatol (2005) 0.75
Twin-twin transfusion syndrome. Semin Perinatol (2012) 0.75
The North American Fetal Therapy Network consensus statement: prenatal surveillance of uncomplicated monochorionic gestations. Obstet Gynecol (2015) 0.75
Diagnosis and management of obstetrical complications unique to multiple gestations. Clin Obstet Gynecol (2004) 0.75
Peripartum management of dual antiplatelet therapy and neuraxial labor analgesia after bare metal stent insertion for acute myocardial infarction. Anesth Analg (2012) 0.75
Placental hematoma mimicking twin anemia-polycythemia sequence following selective laser photocoagulation for twin-twin transfusion syndrome. Prenat Diagn (2014) 0.75
Safety of conservative management of ovarian masses during pregnancy. J Reprod Med (2013) 0.75